|
1
|
Gaedcke J, Grade M, Camps J, Søkilde R,
Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi
BM, Møller S, et al: The rectal cancer microRNAome-microRNA
expression in rectal cancer and matched normal mucosa. Clin Cancer
Res. 18:4919–4930. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Slattery ML, Wolff E, Hoffman MD, Pellatt
DF, Milash B and Wolff RK: MicroRNAs and colon and rectal cancer:
Differential expression by tumor location and subtype. Gene
Chromosomes Cancer. 50:196–206. 2011. View Article : Google Scholar
|
|
3
|
Smalheiser NR and Torvik VI: A
population-based statistical approach identifies parameters
characteristic of human microRNA-mRNA interactions. BMC
Bioinformatics. 5:1392004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li P, He QY and Luo CQ: Overexpression of
miR-200b inhibits the cell proliferation and promotes apoptosis of
human hypertrophic scar fibroblasts in vitro. J Dermatol.
41:903–911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao J, Li X, Zou M, He J, Han Y, Wu D,
Yang H and Wu J: miR-135a inhibition protects A549 cells from
LPS-induced apoptosis by targeting Bcl-2. Biochem Bioph Res Commun.
452:951–957. 2014. View Article : Google Scholar
|
|
6
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs-the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
10
|
Michael MZ, O' Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
11
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dore LC, Amigo JD, Dos Santos CO, Zhang Z,
Gai X, Tobias JW, Yu D, Klein AM, Dorman C, Wu W, et al: A
GATA-1-regulated microRNA locus essential for erythropoiesis. P
Natl Acad Sci USA. 105:3333–3338. 2008. View Article : Google Scholar
|
|
13
|
Lawrie CH: microRNA expression in
erythropoiesis and erythroid disorders. Brit J Haematol.
150:144–151. 2010.
|
|
14
|
Sangokoya C, Telen MJ and Chi JT: microRNA
miR-144 modulates oxidative stress tolerance and associates with
anemia severity in sickle cell disease. Blood. 116:4338–4348. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W, Peng B, Wang D, Ma X, Jiang D,
Zhao J and Yu L: Human tumor microRNA signatures derived from
large-scale oligonucleotide microarray datasets. Int J Cancer.
129:1624–1634. 2011. View Article : Google Scholar
|
|
16
|
Lock FE, Ryan KR, Poulter NS, Parsons M
and Hotchin NA: Differential regulation of adhesion complex
turnover by ROCK1 and ROCK2. PloS One. 7:e314232012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schmandke A, Schmandke A and Strittmatter
SM: ROCK and Rho: Biochemistry and neuronal functions of
Rho-associated protein kinases. Neuroscientist. 13:454–469. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Madaule P, Furuyashiki T, Eda M, Bito H,
Ishizaki T and Narumiya S: Citron, a Rho target that affects
contractility during cytokinesis. Microsc Res Tech. 49:123–126.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Narumiya S, Tanji M and Ishizaki T: Rho
signaling, ROCK and mDia1, in transformation, metastasis and
invasion. Cancer Metast Rev. 28:65–76. 2009. View Article : Google Scholar
|
|
20
|
Wilkinson S, Paterson HF and Marshall CJ:
Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin
phosphorylation and cell invasion. Nat Cell Biol. 7:255–261. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin SL, Chiang A, Chang D and Ying SY:
Loss of mir-146a function in hormone-refractory prostate cancer.
RNA. 14:417–424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Simionescu N, Niculescu LS, Sanda GM,
Margina D and Sima AV: Serum microRNA profiling of hyperlipidemic
and/or hyperglycemic patients reveals specifically increased levels
of miR-122, miR-125a, miR-486 and miR-92a. Ann Rom Soc Cell Biol.
19:53–64. 2014.
|
|
23
|
Zheng LH, Zhang DZ, Zhang YF, Wen YH and
Wang YC: mTOR signal transduction pathways contribute to TN-C FNIII
A1 overexpression by mechanical stress in osteosarcoma cells. Mol
Cells. 37:118–125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han L, Liang XH, Chen LX, Bao SM and Yan
ZQ: SIRT1 is highly expressed in brain metastasis tissues of
non-small cell lung cancer (NSCLC) and in positive regulation of
NSCLC cell migration. Int J Clin Exp Patho. 6:23572013.
|
|
25
|
Zha W, Cao L, Shen Y and Huang M: Roles of
Mir-144-ZFX pathway in growth regulation of non-small-cell lung
cancer. PLoS One. 8:e741752013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Walter BA, Valera VA, Pinto PA and Merino
MJ: Comprehensive microRNA profiling of prostate cancer. J Cancer.
4:350–357. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao T, Li H, Hu Y, Ma D and Cai X: miR-144
suppresses the proliferation and metastasis of hepatocellular
carcinoma by targeting E2F3. Tumor Biol. 35:10759–10764. 2014.
View Article : Google Scholar
|
|
28
|
Fu YF, Du TT, Dong M, Zhu KY, Jing CB,
Zhang Y, Wang L, Fan HB, Chen Y, Jin Y, et al: Mir-144 selectively
regulates embryonic alplha-hemoglobin synthesis during primitive
erythropoiesis. Blood. 113:1340–1349. 2009. View Article : Google Scholar
|
|
29
|
Sangokoya C, Telen MJ and Chi JT: microRNA
miR-144 modulates oxidative stress tolerance and associates with
anemia severity in sickle cell disease. Blood. 116:4338–4348. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao M, Huang J, Gui K, Xiong M, Cai G, Xu
J, Wang K, Liu D, Zhang X and Yin W: The downregulation of miR-144
is associated with the growth and invasion of osteosarcoma cells
through the regulation of TAGLN expression. Int J Mol Med.
34:1565–1572. 2014.PubMed/NCBI
|
|
32
|
Guan H, Liang W, Xie Z, Li H, Liu J, Liu
L, Xiu L and Li Y: Down-regulation of miR-144 promotes thyroid
cancer cell invasion by targeting ZEB1 and ZEB2. Endocrine.
48:566–574. 2015. View Article : Google Scholar
|
|
33
|
Wen X, Ding L, Wang JJ, Qi M, Hammonds J,
Chu H, Chen X, Hunter E and Spearman P: ROCK1 and LIM Kinase
modulate retrovirus particle release and cell-cell transmission
events. J Virol. 88:6906–6921. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC,
Lee JH, Lee SS, Ashktorab H, Smoot DT, Ryu KW, et al: MicroRNA 135a
suppresses lymph node metastasis through down-regulation of ROCK1
in early gastric cancer. PLoS One. 9:e852052014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rath N and Olson MF: Rho-associated
kinases in tumorigenesis: re-considering ROCK inhibition for cancer
therapy. EMBO Rep. 13:900–908. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu X, Choy E, Hornicek FJ, Yang S, Yang
C, Harmon D, Mankin H and Duan Z: ROCK1 as a potential therapeutic
target in osteosarcoma. J Orthop Res. 29:1259–1266. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vigil D, Kim TY, Plachco A, Garton AJ,
Castaldo L, Pachter JA, Dong H, Chen X, Tokar B, Campbell SL, et
al: ROCK1 and ROCK2 are required for non-small cell lung cancer
anchorage-independent growth and invasion. Cancer Res.
72:5338–5347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang C, Zhang S, Zhang Z, He J, Xu Y and
Liu S: ROCK has a crucial role in regulating prostate tumor growth
through interaction with c-Myc. Oncogene. 33:5582–5591. 2014.
View Article : Google Scholar
|
|
39
|
Zhou X, Wei M and Wang W: MicroRNA-340
suppresses osteosarcoma tumor growth and metastasis by directly
targeting ROCK1. Biochem Biophys Res Commun. 437:653–658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ueno K, Hirata H, Shahryari V, Chen Y,
Zaman MS, Singh K, Tabatabai ZL, Hinoda Y and Dahiya R: Tumour
suppressor microRNA-584 directly targets oncogene Rock-1 and
decreases invasion ability in human clear cell renal cell
carcinoma. Br J Cancer. 104:308–315. 2011. View Article : Google Scholar :
|
|
41
|
Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and
Deng L: miR-124 inhibits growth and invasion of gastric cancer by
targeting ROCK1. Asian Pac J Cancer Prev. 15:6543–6546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
